Close

Notable Analyst Rating Changes 11/14: (CRM) (CAT) (APKT) Upgraded; (PFE) (BCS) (PHM) Downgraded Nov 14, 2011 11:22AM
Barclays Maintains an 'Overweight' on PAREXEL (PRXL); Some Positives, But Still a Show Me Nov 1, 2011 02:22PM
Barclays on U.S. Major Pharmaceuticals: Q3 Preview: BMY and PFE to Stand Apart From the Defensive Play Story Oct 13, 2011 02:32PM
UPDATE - Barclays Downgraded Pfizer (PFE) to Equalweight; Inferior Revenue Recovery Post 'Patent Cliff' Through 2020 Sep 14, 2011 12:45PM
Notable Analyst Rating Changes 09/14: (ORCL) (HIG) (MMC) Upgraded; (PFE) (CEDC) (JASO) Downgraded Sep 14, 2011 11:21AM


Sep 14, 2011 06:50AM Barclays Downgrades Pfizer (PFE) to Equalweight
Jun 27, 2011 02:53PM Notable 52-Week Highs and Lows of the Day 06/27: (ICGN) (CROX) (SAPE) High; (PTIE) (HOGS) (DWA) Low
Jun 23, 2011 03:27PM Barclays Maintains an 'Overweight' on Bristol-Myers (BMY); ARISTOTLE Delivers One-Two Punch; Eliquis Poised to be the Market Leader
Jun 10, 2011 03:21PM Barclays on U.S. Major Pharmaceuticals: Pipelines Revived? Making Strides in Oncology, Cardiology, and Virology
May 16, 2011 02:05PM Global Pharmaceuticals: Global Therapeutic Conference 2011: Focus on Real-World Medicine
Apr 14, 2011 01:25PM Barclays on U.S. Major Pharmaceuticals: 1Q11 Preview: Restructuring or New Products - Which Is The Lifeline For Pharma?
Apr 6, 2011 01:07PM Barclays Maintains an 'Overweight' on Pfizer (PFE); Model Update: Capsugel Sale As Expected
Mar 21, 2011 01:28PM Barclays on U.S. Specialty Pharmaceuticals: Mylan Influencing Lipitor Landscape?
Feb 2, 2011 01:30PM Barclays Maintains an 'Overweight' on Pfizer (PFE); Q4 Review: Making the Right Moves
Jan 24, 2011 02:50PM Barclays on U.S. Major Pharmaceuticals: U.S. Major Pharma 2011 Outlook: A View Beyond the Cliff
Oct 13, 2010 12:57PM Barclays Maintains an 'Overweight' on Pfizer (PFE); King Acquisition: Good But Not Great
Oct 7, 2010 02:49PM Barclays Maintains an 'Overweight' Rating on Pfizer (PFE); Grange Castle, Ireland Tour: Pfizer Emphasizes the Prevnar Family
Sep 28, 2010 02:33PM Barclays Pipeline Update on Pfizer (PFE): Increasing Pressure for Apixaban and Tasocitinib to Perform
Jul 27, 2010 02:42PM Barclays Maintains an 'Overweight' on Pfizer (PFE); Pipeline Dimming; Capital Allocation Comes Into Focus
Feb 18, 2010 01:38PM Loeb's Third Point Q4 13F Breakdown: Ups Bets In Financials, Exits Large Pharma
Oct 19, 2009 11:11AM Notable Analyst Rating Changes 10/19: AXP, NOV, EL, DKS Upgrade; FNM/FRE, ANF, MAT, LUV Downgrade
Oct 19, 2009 08:18AM Barclays Resumes Coverage on Pfizer (PFE) with an Overweight
Feb 9, 2009 10:21AM David Moenning's Daily State of the Markets: 2/9
Feb 2, 2009 10:04AM David Moenning's Daily State of the Markets: 2/2
Feb 2, 2009 09:52AM Notable Analyst Rating Changes 2/2: PFE, ESRX, CLX, AKAM Upgraded; F, NYX, ETFC, WU Downgraded
Jan 26, 2009 09:50AM Morning Movers 1/26: Barclays plc (BCS) Up After Easing Concerns; Rohm and Haas (ROH) Slammed As Dow Walks
Jan 23, 2009 10:03AM Morning Movers 1/23: Wyeth (WYE) Higher On Bid Report; Microsemi (MSCC) Slammed On Results/Guidance
Jan 12, 2009 10:13AM Notable Analyst Rating Changes 1/12: CFR, PALM, PFE Upgraded; AA, HOG, MDAS, BNI Downgraded
Oct 20, 2008 10:36AM David Moenning's Daily State of the Markets: 10/20
Oct 20, 2008 09:55AM Notable Analyst Rating Changes 10/20: KFT, RIG, BBY, PFE, YGE Upgraded; DE, INTC, MET, POZN Downgraded
Oct 20, 2008 08:41AM Barclays Capital Upgrades Pfizer (PFE) to Overweight
Sep 3, 2008 09:28AM Pre-Open Movers 9/3: Medivation (MDVN) Surges On Pfizer Deal; Corning (GLW) Sinks on Warning